|Description||SIB 1553A hydrochloride is a nicotinic acetylcholine receptor (nAChR) agonist with selectivity for β4 subunit-containing receptors. It stimulates acetylcholine levels and other neurotransmitters relevant for cognitive processes, and acts as a cognitive enhancer potentially used for the treatment of Alzheimer's disease (AD).|
|Brife Description||nAChR agonist|
|Purity||≥98% by HPLC|
|Related CAS||191611-76-4 (free base)|
|Synonyms||SIB1553A; SIB 1553A; SIB-1553A; (±)-4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride|
|Application||potential treatment of Alzheimer's disease|
Varenicline(CP 526555; Champix; Chantix) is a prescription medication used to treat smoking addiction. As a partial agonist it both reduces cravings for and dec...
Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent.
1-Acetyl-4-methylpiperazine hydrochloride is the hydrochloride salt of 1-Acetyl-4-methylpiperazine which is a structural analog of acetylcholine. It acts as a n...
The hydrochloride salt form of CMPI, which is an effective potentiator of nAChRs and shows activities to photoincorporate into aliphatic and nucleophilic amino ...
SR 16584 is a selective α3β4 nAChR antagonist (IC50 = 10.2 μM) with selectivity for α3β4 over α4β2 and α7 subtypes (Ki = 0.508, >100 and >100 μM, respectively).
DMAB-anabaseine dihydrochloride is a partial agonist at α7-containing neuronal nicotinic receptors and antagonist at α4β2 and other nicotinic receptors. It pote...
Vecuronium bromide (Norcuron) is a muscle relaxant in the category of non-depolarizing blocking agents. Vecuronium bromide is indicated as an adjunct to general...